Keywords: hybridon, antisense, trials, imminent, specialist, awaiting, approval

HYBRIDON ANTISENSE TRIALS IMMINENT?

Article | 08 February 1993

US antisense specialist Hybridon is awaiting approval from the US Food and Drug Administration and expects to begin clinical trials ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in